Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’-Reference-Cited by-同舟云学术

Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’

Published:2022-10-01 Issue:10 Volume:47 Page:1864-1865
ISSN:1365-2230
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Martora Fabrizio¹^ORCID,Marasca Claudio¹^ORCID,Fabbrocini Gabriella¹,Ruggiero Angelo¹^ORCID

Affiliation:

1. Dermatology Unit, Department of Clinical Medicine and Surgery University of Naples Federico II Naples Italy

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.15291

Reference11 articles.

1. Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?;Ring;Clin Exp Dermatol,2022

2. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance;Marasca;Br J Dermatol,2019

3. Isotretinoin in the treatment of hidradenitis suppurativa: a retrospective study;Patel;J Dermatolog Treat,2021

4. A case of pemphigus vulgaris and hidradenitis suppurativa: may systemic steroids be considered in the standard management of hidradenitis suppurativa?;Martora;Skin Appendage Disord,2022

5. Adalimumab dose intensification in recalcitrant hidradenitis suppurativa/acne inversa;Zouboulis;Dermatology,2020

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature;Medicina;2024-09-06

2. Viral reactivation following COVID-19 vaccination: a review of the current literature;Clinical and Experimental Dermatology;2024-02-20

3. Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-02

4. Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review;Clinical, Cosmetic and Investigational Dermatology;2024-01

5. Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study;Clinical, Cosmetic and Investigational Dermatology;2024-01